| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, Chair of the Board | Director
3 companies
Lars Ekman is Director at RARE and has filed Form 4s across 3 companies. Lars Ekman's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $297K at current prices.
Historically, Lars Ekman's trades have earned a strong insider score of 73/100 across 5 rated trades. Over a 12-month horizon, all 5 of those trades were profitable, with an average 12-month return of +30.6%.
The biggest single holding is RARE (~$295K) as Director.
Lars Ekman has 40 Form 4 filings on record from May 2015 to May 2026, across 3 companies: Director at Prothena (PRTA), 2015–2026; Director at Amarin Corp Plc\uk (AMRN), 2015–2022; Director at Ultragenyx Pharmaceutical (RARE), 2016–2022.
The 100 reported transactions were 41 option or other derivative awards, 31 open-market sales, 18 option exercises and 7 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 11 sales worth about $15.1M.
The largest open-market sale was 135,377 shares of AMRN at an average $21.31 on March 4, 2019, about $2.9M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | PRTA Prothena Corp Public Ltd Co | Director, Chair of the Board | Sale+OE | 15,834 | $55.98 | $886,407.43 | -98.5% | -9.0% | -28.9% | |
| Dec 1, 2022 | PRTA Prothena Corp Public Ltd Co | Director, Chair of the Board | Sale+OE | 15,834 | $61.60 | $975,406.24 | -98.5% | -8.1% | -42.7% | |
| Nov 1, 2022 | PRTA Prothena Corp Public Ltd Co | Director, Chair of the Board | Sale+OE | 15,833 | $62.88 | $995,657.87 | -98.5% | -13.4% | -42.2% | |
| Oct 3, 2022 | PRTA Prothena Corp Public Ltd Co | Director, Chair of the Board | Sale+OE | 15,833 | $61.52 | $974,081.55 | -98.5% | -13.5% | -23.2% | |
| Sep 28, 2022 | PRTA Prothena Corp Public Ltd Co | Director, Chair of the Board | Sale+OE | 31,666 | $48.09 | $1,522,817.94 | -99.2% | -2.4% | -15.8% | |
| Nov 12, 2019 | AMRN Amarin Corp Plc\uk | Director | Sale+OE | 38,600 | $19.35 | $746,759.46 | - | - | - | |
| Nov 5, 2019 | AMRN Amarin Corp Plc\uk | Director | Sale+OE | 6,400 | $18.00 | $115,230.08 | - | - | - | |
| Sep 3, 2019 | AMRN Amarin Corp Plc\uk | Director | Sale+OE | 91,016 | $15.01 | $1,365,722.38 | - | - | - | |
| Mar 4, 2019 | AMRN Amarin Corp Plc\uk | Director | Sale+OE | 135,377 | $21.31 | $2,884,904.79 | - | - | - | |
| Jan 10, 2019 | AMRN Amarin Corp Plc\uk | Director | Sale+OE | 140,416 | $17.28 | $2,426,489.35 | - | - | - |